bioRxivCancer BiologyPreprint
Bead Enhancement of EV Analysis
Hsing-Ying Lin, Katherine S. Yang, Caleigh Curley, Hakho LeeiD, Marisa W. Welch, Brian M. Wolpin, Ralph WeisslederiD, Hyungsoon ImiD, Cesar Castro
Abstract
Extracellular vesicles (EVs) are recognized cancer biomarkers, however, clinical analysis has been difficult due to a lack of simple and sensitive assays. Here, we describe a bead-enhanced flow cytometry method, BEAD flow, using biotinylated EVs captured on streptavidin particles. With this method, we show analysis of patient-derived EVs using a panel of pancreatic cancer biomarkers. BEAD flow is easily translatable to any biomarker or cancer type and can be run with conventional flow cytometers, making it highly flexible and adaptable to diverse research and clinical needs.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Customizable bead-based platform for EV surface protein immunocapture and detection in plasma
Hema Saranya Ilamathi, Mariana Castaneda Mesa, … Oscar P. B. Wiklander·bioRxiv·Oct 29, 2026
- A simple immunoassay for extracellular vesicle liquid biopsy in microliters of non-processed plasma
C. Campos-Silva, Y. Caceres-Martell, … M. Vales-Gomez·bioRxiv·Sep 20, 2021
- Dedicated nanoparticle flow cytometry for single extracellular vesicle phenotyping: Performance of the CytoFLEX Nano
Johann Mar Gudbergsson, Mette Galsgaard Malle, … Anja Bille Bohn·bioRxiv·Dec 17, 2025
- Nano Pom-poms Prepared Highly Specific Extracellular Vesicles Expand the Detectable Cancer Biomarkers
M. He·bioRxiv·Feb 21, 2021
- EVQuant; high-throughput quantification and characterization of extracellular vesicle (sub)populations
T. A. Hartjes, J. A. Slotman, … M. E. van Royen·bioRxiv·Oct 21, 2020
- Advancing Nano-Flow Cytometry: High-Precision Sorting and Analysis of Extracellular Vesicles
Irene Castrosín, Vanessa Costa, … Margaret M. Mc Gee·bioRxiv·Jul 28, 2026